Clinical Trial Update: Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the metabolic effects of resveratrol in insulin resistance/metabolic syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of California, San Francisco | Conditions: Insulin Resistance | Phase 2 | Status: WITHDRAWN